share_log

Nikola | EFFECT: Others

Nikola | EFFECT: Others

Nikola | EFFECT:其他
美股SEC公告 ·  08/29 06:25
Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.
美国证券交易委员会(SEC)宣布了对TC BioPharm(Holdings)plc的F-1表格的生效。通知表明该表格于2024年8月28日下午4:00生效。这种表格通常由外国私人发行人用于在美国注册其证券销售。该表格的生效表示TC BioPharm(Holdings)plc已满足必要的SEC要求,可以继续销售其证券。
美国证券交易委员会(SEC)宣布了对TC BioPharm(Holdings)plc的F-1表格的生效。通知表明该表格于2024年8月28日下午4:00生效。这种表格通常由外国私人发行人用于在美国注册其证券销售。该表格的生效表示TC BioPharm(Holdings)plc已满足必要的SEC要求,可以继续销售其证券。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息